Databases in MS research: Pitfalls and promises

Multiple Sclerosis

Volumn 5, Issue 4, 1999, Pages 206-211

  Weinshenker, Brian G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Databases; Epidemiology; Multiple sclerosis; Natural history; Prognosis; Therapy

Indexed keywords

BETA INTERFERON;

CLINICAL TRIAL; CONFERENCE PAPER; DATA BASE; HUMAN; LONG TERM CARE; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; PATIENT INFORMATION; STATISTICS;

EID: 0032863327     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859900500402     Document Type: Conference Paper

References (18)

1. Kurtzke JF, Beebe GW, Norman Jr JE. [1979] Epidemiology of multiple sclerosis in U.S. veterans. 1. Race, sex, and geographic distribution. Neurology 29: 1228-1235.
2. Kurtzke JF et al. (1973) Studies on the natural history of multiple sclerosis. 7. Correlates of clinical change in an early bout. Acta Neurologica Scandinavica 49: 379-395.
3. Kurtzke JF et al. (1977) Studies on the natural history of multiple sclerosis VIII. Early prognostic features of the later course of the illness. J Chronic Dis 30: 819-830.
4. McGee M. (1996) Databases for psychiatrists. Harvard Rev Psychiatry 4: 139-145.
5. Weinshenker BG, Ebers GC. (1987) The natural history of multiple sclerosis. Can J Neurol Sci 14: 255-261.
6. Boiko A. (1997) Guidelines for questionnaires to be used in case-control studies of multiple sclerosis. Neurology (Suppl 2) 49: 575-580.
7. Higgins M. (1984) The Framingham Heart Study: Review of epidemiological design and data, limitations and prospects. In: Rao DC ER, Kueler LH, et al. (ed) Genetic Epidemiology of Coronary Heart Disease: Past, Present, and Future. New York: Alan R. Liss, Inc., 51-64.
8. Siva A et al. (1993) Trauma and multiple sclerosis: A population-based cohort study from Olmsted County, Minnesota. Neurology 13: 1878-1882.
9. Haahr S et al. (1995) Increased risk of multiple sclerosis after late Epstein-Barr virus infection: A historical prospective study. Multiple Sclerosis 1: 73-77.
10. Bronnum-Hansen H. (1994) Survival of patients with multiple sclerosis in Denmark: A nationwide, long-term epidemiologic survey. Neurology 44: 1901-1907.
11. Pincus T. (1988) Rheumatoid Arthritis: Disappointing long-term outcomes despite successful short-term clinical trials. J Clin Epidemiol (Editorial) 41: 1037-1041.
12. Wolfe F, Pincus T. (1995) Data collection in the clinic. Rheumatic Disease Clinics of North America 21: 321-358.
13. Pincus T, Stein C. (1995) What is the best source of useful data on the treatment of rheumatoid arthritis: clinical trials, clinical observations, or clinical protocols? (Editorial) Journal of Rheumatology 22: 1611-1617.
14. Weinshenker BG et al. (1989) The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability. Brain 112: 133-146.
15. Runmarker B, Anderson O. (1993) Prognostic factors in a multiple sclerosis incidence cohort with 25 years of follow-up. Brain 116: 117-134.
16. Kantarci O et al. (1998) Survival and predictors of disability in Turkish MS patients. Neurology 51: 765-772.
17. Austin HR et al. (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. New England Journal of Medicine 314: 614-619.
18. Gabriel S et al. (1994) Risk of connective-tissue disease and other disorders after breast implantation. New England J Med 330: 1697-1702.